This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

A simple regimen of 1 pill per day with no intake break to maximise compliance

A 28-day regimen with no intake break is likely to have higher compliance rates than those with an intake break.

Qlaira pills pack shot

Each wallet (28 film-coated tablets) contains:

  • 2 dark yellow tablets each containing 3 mg estradiol valerate​

  • 5 medium red tablets each containing 2 mg estradiol valerate and 2 mg dienogest​

  • 17 light yellow tablets each containing 2 mg estradiol valerate and 3 mg dienogest​

  • 2 dark red tablets each containing 1 mg estradiol valerate​

  • 2 white tablets that do not contain active substances​

​To assist patients, the missed pill rules are printed directly on to the Qlaira® wallet.​

Qlaira Content Card
Qlaira® (Estradiol valerate/dienogest) | FAQs
Discover frequently asked questions about Qlaira®.
PP-QLA-IE-0003-1, January 2026
arrow_forward
Qlaira Content Card
Qlaira® (Estradiol valerate/dienogest)
Discover more about intended use of Qlaira®
PP-QLA-IE-0001-1, January 2026
arrow_forward
Qlaira Content Card
Qlaira® (Estradiol valerate/dienogest) | Estradiol Valerate
Learn more about Qlaira® Estradiol Valerate.
PP-QLA-IE-0002-1, January 2026
arrow_forward

PP-QLA-IE-0004-1   |   January 2026


    • 1
      Qlaira® (Estradiol valerate/dienogest) Summary of Product Characteristics.